Redwire Corporation - $RDW STOCK NEWS

Redwire (NYSE: RDW) has been awarded a contract by the European Space Agency (ESA) to develop a robotic arm prototype for the Argonaut Lunar Lander. This robotic arm, known as the MANUS system, will facilitate critical logistics operations on the lunar surface, including the offloading, positioning, and retrieval of objects, as well as the positioning of the lander. The development will take place at Redwire’s Luxembourg facility, and the project aims to meet high standards of performance, reliability, and safety. Redwire has a strong track record in space robotics, having previously developed the STAARK robotic arm and contributed to various ambitious space missions. This contract further strengthens Redwire’s portfolio in lunar infrastructure projects, which includes partnerships with NASA and DARPA for other lunar surface developments.

Redwire (NYSE: RDW) has been awarded a NASA/JPL contract to study a commercial Mars spacecraft that will use Redwire's heritage technology to provide surface imagery. This project aims to support future Mars missions, offering high-resolution imagery for scientific investigations, hazard assessments, landing site selection, and asset monitoring. Redwire will leverage its proven spacecraft systems and the Blue Ring platform from its partner, Blue Origin, for this mission. This effort highlights Redwire’s capabilities in space infrastructure, important for various missions in low Earth orbit, cislunar space, and beyond. The spacecraft bus design is based on Redwire's satellite bus, which has operated successfully for over 40 years.

Redwire (NYSE: RDW) announced the development of Phantom, a new European Very Low Earth Orbit (VLEO) spacecraft platform, reinforcing their international leadership in VLEO capabilities. Phantom, designed to carry out intelligence, Earth science, and communications missions, leverages over four decades of satellite design heritage, reducing propellant requirements and staying in VLEO for up to five years. Redwire is advancing Phantom's design through the European Space Agency's VLEO mission: Skimsat, focusing on boosting satellite sustainability and mission performance while reducing costs.

Redwire reported strong financial results for the first quarter of 2024, with a 52.4% increase in revenues to $87.8 million. The company achieved positive Adjusted EBITDA of $4.3 million and saw significant improvements in net cash flow from operating activities and free cash flow. Redwire also increased its pipeline to $6.3 billion, with $610.0 million in bids submitted year-to-date. The company remains optimistic about its growth prospects and forecasts revenues of $300 million for the full year 2024.

Redwire (NYSE: RDW) successfully 3D bioprinted live human heart tissue on the International Space Station, marking a significant advancement in space biotech capabilities. The company also delivered a second batch of pharmaceutical crystal experiments from its PIL-BOX platform. The bioprinting of heart tissue and crystal experiments in microgravity opens up new possibilities for drug discovery and development, potentially leading to more effective treatments for patients. Redwire's partnership with Eli Lilly and Co. highlights its commitment to advancing space biotech capabilities.

Redwire (NYSE: RDW) has been selected by Rocket Lab to provide antennas and RF hardware for the Space Development Agency's Transport Layer Tranche 2 Satellite Constellation. This partnership will support the development of the Proliferated Warfighter Space Architecture (PWSA) to enhance secure communication for warfighters on land, in the air, and at sea. Redwire's significant investments in manufacturing capacity and assembly, integration, and test capacity highlight their commitment to the program. The company will produce 18 ship sets of antennas and RF front ends for Tranche 2 at its newly expanded Colorado facility, ensuring the success of the project.

Redwire (NYSE: RDW) will report financial results for the first quarter ended March 31, 2024, on May 8, 2024. A conference call will be held on May 9, 2024, to review the results. The earnings call can be accessed via phone or webcast. Replay options will be available for those unable to attend live. Details are provided on the company's investor relations website.

Redwire (NYSE: RDW) has signed a memorandum of understanding (MOU) with Boryung to support Boryung's Humans In Space program, aiming to advance global human health through space research. Redwire will facilitate research experiments on-orbit, provide mission management services, and partner for the Humans In Space challenge. The partnership will leverage Redwire's expertise in microgravity research and on-orbit investigation management to support research proposals submitted through the program.

Redwire (NYSE: RDW) reports a strong financial performance in 2023 with significant revenue growth, improved net loss, and positive Adjusted EBITDA. The company achieved four consecutive quarters of revenue growth and positive Adjusted EBITDA, with a Contracted Backlog of $372.8 million at the start of 2024. Redwire forecasts revenues of $300 million for the full year ending December 31, 2024.